Preface |
|
xix | |
About the Companion Website |
|
xxi | |
|
Part I General Introduction |
|
|
1 | (20) |
|
1 BiomateriaLs -- An Introductory Overview |
|
|
3 | (18) |
|
|
3 | (1) |
|
1.2 Definition and Meaning of Common Terms |
|
|
3 | (5) |
|
1.3 Biomaterials Design and Selection |
|
|
8 | (3) |
|
1.3.1 Evolving Trend in Biomaterials Design |
|
|
8 | (1) |
|
1.3.2 Factors in Biomaterials Design and Selection |
|
|
9 | (2) |
|
1.4 Properties of Materials |
|
|
11 | (2) |
|
1.4.1 Intrinsic Properties of Metals |
|
|
11 | (1) |
|
1.4.2 Intrinsic Properties of Ceramics |
|
|
11 | (1) |
|
1.4.3 Intrinsic Properties of Polymers |
|
|
12 | (1) |
|
1.4.4 Properties of Composites |
|
|
12 | (1) |
|
1.4.5 Representation of Properties |
|
|
13 | (1) |
|
1.5 Case Study in Materials Design and Selection: The Hip Implant |
|
|
13 | (4) |
|
1.6 Brief History of the Evolution of Biomaterials |
|
|
17 | (2) |
|
1.7 Biomaterials -- An Interdisciplinary Field |
|
|
19 | (1) |
|
|
19 | (2) |
|
Part II Materials Science of Biomaterials |
|
|
21 | (98) |
|
2 Atomic Structure and Bonding |
|
|
23 | (24) |
|
|
23 | (1) |
|
2.2 Interatomic Forces and Bonding Energies |
|
|
23 | (3) |
|
2.3 Types of Bonds between Atoms and Molecules |
|
|
26 | (1) |
|
|
27 | (7) |
|
|
29 | (1) |
|
|
30 | (3) |
|
|
33 | (1) |
|
|
34 | (2) |
|
2.5.1 Van der Waals Bonding |
|
|
34 | (1) |
|
|
35 | (1) |
|
2.6 Atomic Bonding and Structure in Proteins |
|
|
36 | (8) |
|
|
36 | (1) |
|
2.6.2 Secondary Structure |
|
|
37 | (1) |
|
|
38 | (5) |
|
2.6.4 Quaternary Structure |
|
|
43 | (1) |
|
|
44 | (3) |
|
|
47 | (22) |
|
|
47 | (1) |
|
3.2 Packing of Atoms in Crystals |
|
|
47 | (4) |
|
3.2.1 Unit Cells and Crystal Systems |
|
|
49 | (2) |
|
3.3 Structure of Solids Used as Biomaterials |
|
|
51 | (7) |
|
3.3.1 Crystal Structure of Metals |
|
|
51 | (1) |
|
3.3.2 Crystal Structure of Ceramics |
|
|
52 | (2) |
|
3.3.3 Structure of Inorganic Glasses |
|
|
54 | (1) |
|
3.3.4 Structure of Carbon Materials |
|
|
55 | (2) |
|
3.3.5 Structure of Polymers |
|
|
57 | (1) |
|
3.4 Defects in Crystalline Solids |
|
|
58 | (4) |
|
|
59 | (1) |
|
3.4.2 Line Defects: Dislocations |
|
|
59 | (3) |
|
3.4.3 Planar Defects: Surfaces and Grain Boundaries |
|
|
62 | (1) |
|
3.5 Microstructure of Biomaterials |
|
|
62 | (3) |
|
3.5.1 Microstructure of Dense Biomaterials |
|
|
63 | (1) |
|
3.5.2 Microstructure of Porous Biomaterials |
|
|
64 | (1) |
|
3.6 Special Topic: Lattice Planes and Directions |
|
|
65 | (2) |
|
|
67 | (2) |
|
4 Bulk Properties of Materials |
|
|
69 | (30) |
|
|
69 | (1) |
|
4.2 Mechanical Properties of Materials |
|
|
69 | (15) |
|
4.2.1 Mechanical Stress and Strain |
|
|
70 | (2) |
|
|
72 | (2) |
|
4.2.3 Mechanical Response of Materials |
|
|
74 | (4) |
|
4.2.4 Stress-Strain Behavior of Metals, Ceramics, and Polymers |
|
|
78 | (1) |
|
4.2.5 Fracture of Materials |
|
|
79 | (3) |
|
4.2.6 Toughness and Fracture Toughness |
|
|
82 | (1) |
|
|
82 | (1) |
|
|
83 | (1) |
|
4.3 Effect of Microstructure on Mechanical Properties |
|
|
84 | (1) |
|
|
84 | (1) |
|
4.3.2 Effect of Grain Size |
|
|
85 | (1) |
|
4.4 Designing with Ductile and Brittle Materials |
|
|
85 | (2) |
|
4.4.1 Designing with Metals |
|
|
85 | (1) |
|
4.4.2 Designing with Ceramics |
|
|
85 | (2) |
|
4.4.3 Designing with Polymers |
|
|
87 | (1) |
|
4.5 Electrical Properties |
|
|
87 | (1) |
|
4.5.1 Electrical Conductivity of Materials |
|
|
87 | (1) |
|
4.5.2 Electrical Conductivity of Conducting Polymers |
|
|
88 | (1) |
|
|
88 | (4) |
|
4.6.1 Origins of Magnetic Response in Materials |
|
|
88 | (1) |
|
4.6.2 Meaning and Definition of Relevant Magnetic Properties |
|
|
89 | (1) |
|
4.6.3 Diamagnetic and Paramagnetic Materials |
|
|
89 | (1) |
|
4.6.4 Ferromagnetic Materials |
|
|
90 | (1) |
|
4.6.5 Ferrimagnetic Materials |
|
|
91 | (1) |
|
4.6.6 Magnetization Curves and Hysteresis |
|
|
91 | (1) |
|
4.6.7 Hyperthermia Treatment of Tumors using Magnetic Nanoparticles |
|
|
91 | (1) |
|
|
92 | (2) |
|
4.7.1 Thermal Conductivity |
|
|
92 | (1) |
|
4.7.2 Thermal Expansion Coefficient |
|
|
93 | (1) |
|
|
94 | (1) |
|
|
95 | (4) |
|
5 Surface Properties of Materials |
|
|
99 | (20) |
|
|
99 | (1) |
|
|
100 | (4) |
|
5.2.1 Determination of Surface Energy of Materials |
|
|
101 | (1) |
|
5.2.2 Measurement of Contact Angle |
|
|
102 | (2) |
|
5.2.3 Effect of Surface Energy |
|
|
104 | (1) |
|
|
104 | (4) |
|
5.3.1 Characterization of Surface Chemistry |
|
|
105 | (3) |
|
|
108 | (2) |
|
5.4.1 Surface Charging Mechanisms |
|
|
108 | (1) |
|
5.4.2 Measurement of Surface Charge and Potential |
|
|
109 | (1) |
|
5.4.3 Effect of Surface Charge |
|
|
110 | (1) |
|
|
110 | (6) |
|
5.5.1 Surface Roughness Parameters |
|
|
112 | (1) |
|
5.5.2 Characterization of Surface Topography |
|
|
112 | (13) |
|
5.5.3 Effect of Surface Topography on Cell and Tissue Response |
|
|
125 | |
|
|
116 | (3) |
|
Part III Classes of Materials Used as Biomaterials |
|
|
119 | (220) |
|
|
121 | (32) |
|
|
121 | (1) |
|
6.2 Crystal Structure of Metals |
|
|
121 | (1) |
|
6.3 Polymorphic Transformation |
|
|
122 | (4) |
|
6.3.1 Formation of Nuclei of Critical Size |
|
|
123 | (1) |
|
6.3.2 Rate of Phase Transformation |
|
|
123 | (1) |
|
6.3.3 Diffusive Transformations |
|
|
124 | (1) |
|
6.3.4 Displacive Transformations |
|
|
125 | (1) |
|
6.3.5 Time-Temperature-Transformation (TTT) Diagrams |
|
|
125 | (1) |
|
|
126 | (1) |
|
6.5 Shape (Morphology) of Phases |
|
|
126 | (1) |
|
|
127 | (2) |
|
|
129 | (2) |
|
6.7.1 Wrought Metal Products |
|
|
129 | (1) |
|
6.7.2 Cast Metal Products |
|
|
130 | (1) |
|
6.7.3 Alternative Production Methods |
|
|
130 | (1) |
|
6.8 Mechanisms for Strengthening Metals |
|
|
131 | (2) |
|
6.8.1 Solid Solution Hardening |
|
|
131 | (1) |
|
6.8.2 Precipitation and Dispersion Hardening |
|
|
131 | (1) |
|
|
131 | (1) |
|
6.8.4 Grain Size Refinement |
|
|
132 | (1) |
|
6.9 Metals Used as Biomaterials |
|
|
133 | (12) |
|
|
133 | (1) |
|
6.9.2 Titanium and Titanium Alloys |
|
|
134 | (3) |
|
6.9.3 Cobalt-Based Alloys |
|
|
137 | (4) |
|
6.9.4 Nickel-Titanium Metals and Alloys |
|
|
141 | (2) |
|
|
143 | (1) |
|
|
144 | (1) |
|
|
144 | (1) |
|
|
145 | (4) |
|
6.10.1 Designing Degradable Metals |
|
|
145 | (1) |
|
6.10.2 Degradable Magnesium Alloys |
|
|
146 | (3) |
|
|
149 | (4) |
|
|
153 | (34) |
|
|
153 | (1) |
|
7.2 Design and Processing of Ceramics |
|
|
154 | (3) |
|
7.2.1 Design Principles for Mechanically Reliable Ceramics |
|
|
154 | (1) |
|
7.2.2 Principles of Processing Ceramics |
|
|
155 | (2) |
|
7.3 Chemically Unreactive Ceramics |
|
|
157 | (5) |
|
|
157 | (1) |
|
|
158 | (2) |
|
7.3.3 Alumina-Zirconia (Al2O3-ZrO2) Composites |
|
|
160 | (1) |
|
7.3.4 Silicon Nitride (Si3N4) |
|
|
161 | (1) |
|
|
162 | (5) |
|
7.4.1 Solubility of Calcium Phosphates |
|
|
163 | (1) |
|
7.4.2 Degradation of Calcium Phosphates |
|
|
164 | (1) |
|
|
164 | (1) |
|
7.4.4 Beta-Tricalcium Phosphate (β-TCP) |
|
|
165 | (1) |
|
7.4.5 Biphasic Calcium Phosphate (BCP) |
|
|
165 | (1) |
|
7.4.6 Other Calcium Phosphates |
|
|
166 | (1) |
|
7.4.7 Mechanical Properties of Calcium Phosphates |
|
|
167 | (1) |
|
7.5 Calcium Phosphate Cement (CPC) |
|
|
167 | (3) |
|
|
168 | (1) |
|
7.5.2 CPC Setting (Hardening) Mechanism |
|
|
168 | (1) |
|
7.5.3 Microstructure of CPCs |
|
|
168 | (1) |
|
|
169 | (1) |
|
|
170 | (1) |
|
|
170 | (2) |
|
7.7.1 Glass Transition Temperature (Tg) |
|
|
171 | (1) |
|
|
171 | (1) |
|
7.7.3 Production of Glasses |
|
|
172 | (1) |
|
7.8 Chemically Unreactive Glasses |
|
|
172 | (1) |
|
|
173 | (6) |
|
7.9.1 Bioactive Glass Composition |
|
|
173 | (1) |
|
7.9.2 Mechanism of Conversion to Hydroxyapatite |
|
|
174 | (1) |
|
7.9.3 Reactivity of Bioactive Glasses |
|
|
175 | (1) |
|
7.9.4 Mechanical Properties of Bioactive Glasses |
|
|
176 | (1) |
|
7.9.5 Release of Ions from Bioactive Glasses |
|
|
177 | (1) |
|
7.9.6 Applications of Bioactive Glasses |
|
|
178 | (1) |
|
|
179 | (4) |
|
7.10.1 Production of Glass-Ceramics |
|
|
179 | (1) |
|
7.10.2 Bioactive Glass-Ceramics |
|
|
180 | (1) |
|
7.10.3 Chemically Unreactive Glass-Ceramics |
|
|
181 | (1) |
|
7.10.4 Lithium Disilicate Glass-Ceramics |
|
|
181 | (2) |
|
|
183 | (4) |
|
8 Synthetic Polymers I: Nondegradable Polymers |
|
|
187 | (30) |
|
|
187 | (1) |
|
8.2 Polymer Science Fundamentals |
|
|
188 | (10) |
|
|
188 | (1) |
|
8.2.2 Linear and Crosslinked Molecules |
|
|
189 | (1) |
|
8.2.3 Molecular Symmetry and Stereoregularity |
|
|
189 | (1) |
|
|
190 | (2) |
|
8.2.5 Molecular Conformation |
|
|
192 | (1) |
|
8.2.6 Glass Transition Temperature (Tg) |
|
|
193 | (1) |
|
8.2.7 Semicrystalline Polymers |
|
|
194 | (3) |
|
8.2.8 Molecular Orientation in Amorphous and Semicrystalline Polymers |
|
|
197 | (1) |
|
8.3 Production of Polymers |
|
|
198 | (1) |
|
|
198 | (1) |
|
|
199 | (1) |
|
8.4 Mechanical Properties of Polymers |
|
|
199 | (2) |
|
8.4.1 Effect of Temperature |
|
|
199 | (1) |
|
8.4.2 Effect of Crystallinity |
|
|
200 | (1) |
|
8.4.3 Effect of Molecular Weight |
|
|
200 | (1) |
|
8.4.4 Effect of Molecular Orientation |
|
|
200 | (1) |
|
8.5 Thermoplastic Polymers |
|
|
201 | (6) |
|
|
201 | (2) |
|
8.5.2 Fluorinated Hydrocarbon Polymers |
|
|
203 | (1) |
|
|
204 | (1) |
|
|
204 | (1) |
|
8.5.5 Polyaryletherketones |
|
|
205 | (1) |
|
8.5.6 Polycarbonate, Polyethersulfone, and Polysulfone |
|
|
206 | (1) |
|
|
206 | (1) |
|
|
206 | (1) |
|
|
207 | (2) |
|
8.6.1 Polydimethylsiloxane (PDMS) |
|
|
208 | (1) |
|
8.7 Special Topic: Polyurethanes |
|
|
209 | (3) |
|
8.7.1 Production of Polyurethanes |
|
|
209 | (1) |
|
8.7.2 Structure---Property Relations in Polyurethanes |
|
|
210 | (1) |
|
8.7.3 Chemical Stability of Polyurethanes in vivo |
|
|
211 | (1) |
|
8.7.4 Biomedical Applications of Polyurethanes |
|
|
212 | (1) |
|
8.8 Water-soluble Polymers |
|
|
212 | (1) |
|
|
213 | (4) |
|
9 Synthetic Polymers II: Degradable Polymers |
|
|
217 | (28) |
|
|
217 | (1) |
|
9.2 Degradation of Polymers |
|
|
217 | (1) |
|
9.3 Erosion of Degradable Polymers |
|
|
218 | (1) |
|
9.4 Characterization of Degradation and Erosion |
|
|
219 | (1) |
|
9.5 Factors Controlling Polymer Degradation |
|
|
219 | (4) |
|
|
219 | (1) |
|
|
220 | (1) |
|
|
221 | (1) |
|
|
222 | (1) |
|
|
222 | (1) |
|
|
223 | (1) |
|
9.6 Factors Controlling Polymer Erosion |
|
|
223 | (2) |
|
|
224 | (1) |
|
|
224 | (1) |
|
9.7 Design Criteria for Degradable Polymers |
|
|
225 | (1) |
|
9.8 Types of Degradable Polymers Relevant to Biomaterials |
|
|
226 | (15) |
|
9.8.1 Poly (α-hydroxy Esters) |
|
|
226 | (4) |
|
|
230 | (1) |
|
|
231 | (2) |
|
9.8.4 Poly (Ortho Esters) |
|
|
233 | (1) |
|
|
234 | (1) |
|
9.8.6 Polyhydroxyalkanoates |
|
|
235 | (1) |
|
9.8.7 Poly (Propylene Fumarate) |
|
|
236 | (1) |
|
9.8.8 Polyacetals and Polyketals |
|
|
237 | (1) |
|
9.8.9 Poly (polyol sebacate) |
|
|
238 | (2) |
|
|
240 | (1) |
|
|
241 | (4) |
|
|
245 | (34) |
|
|
245 | (1) |
|
10.2 General Properties and Characteristics of Natural Polymers |
|
|
246 | (1) |
|
10.3 Protein-Based Natural Polymers |
|
|
246 | (16) |
|
|
247 | (8) |
|
|
255 | (1) |
|
|
256 | (3) |
|
|
259 | (1) |
|
|
260 | (1) |
|
|
261 | (1) |
|
10.4 Polysaccharide-Based Polymers |
|
|
262 | (13) |
|
|
263 | (2) |
|
10.4.2 Sulfated Polysaccharides |
|
|
265 | (2) |
|
|
267 | (2) |
|
|
269 | (2) |
|
|
271 | (1) |
|
|
272 | (2) |
|
10.4.7 Bacterial (Microbial) Cellulose |
|
|
274 | (1) |
|
|
275 | (4) |
|
|
279 | (28) |
|
|
279 | (1) |
|
11.2 Characteristics of Hydrogels |
|
|
279 | (2) |
|
|
281 | (1) |
|
11.4 Creation of Hydrogels |
|
|
281 | (3) |
|
11.4.1 Chemical Hydrogels |
|
|
281 | (1) |
|
11.4.2 Physical Hydrogels |
|
|
282 | (2) |
|
11.5 Characterization of Sol to Gel Transition |
|
|
284 | (1) |
|
11.6 Swelling Behavior of Hydrogels |
|
|
285 | (4) |
|
11.6.1 Theory of Swelling |
|
|
285 | (3) |
|
11.6.2 Determination of Swelling Parameters |
|
|
288 | (1) |
|
11.7 Mechanical Properties of Hydrogels |
|
|
289 | (1) |
|
11.8 Transport Properties of Hydrogels |
|
|
289 | (1) |
|
11.9 Surface Properties of Hydrogels |
|
|
290 | (1) |
|
11.10 Environmentally Responsive Hydrogels |
|
|
291 | (3) |
|
11.10.1 pH Responsive Hydrogels |
|
|
291 | (2) |
|
11.10.2 Temperature Responsive Hydrogels |
|
|
293 | (1) |
|
11.11 Synthetic Hydrogels |
|
|
294 | (5) |
|
11.11.1 Polyethylene Glycol and Polyethylene Oxide |
|
|
294 | (3) |
|
11.11.2 Polyvinyl Alcohol |
|
|
297 | (1) |
|
11.11.3 Polyhydroxyethyl Methacrylate |
|
|
298 | (1) |
|
11.11.4 Polyacrylic Acid and Polymethacrylic Acid |
|
|
298 | (1) |
|
11.11.5 Poly (N-isopropyl acrylamide) |
|
|
298 | (1) |
|
|
299 | (2) |
|
11.13 Applications of Hydrogels |
|
|
301 | (2) |
|
|
301 | (1) |
|
11.13.2 Cell Encapsulation and Immunoisolation |
|
|
302 | (1) |
|
11.13.3 Scaffolds for Tissue Engineering |
|
|
302 | (1) |
|
|
303 | (4) |
|
12 Composite Biomaterials |
|
|
307 | (4) |
|
|
307 | (1) |
|
|
307 | (1) |
|
12.3 Mechanical Properties of Composites |
|
|
307 | (4) |
|
12.3.1 Mechanical Properties of Fiber Composites |
|
|
308 | (1) |
|
12.3.2 Mechanical Properties of Particulate Composites |
|
|
309 | (2) |
|
12 A Biomedical Applications of Composites |
|
|
311 | (4) |
|
|
313 | (2) |
|
13 Surface Modification and Biological Functionalization of Biomaterials |
|
|
315 | (24) |
|
|
315 | (1) |
|
13.2 Surface Modification |
|
|
315 | (1) |
|
13.3 Surface Modification Methods |
|
|
316 | (1) |
|
|
317 | (2) |
|
13.4.1 Plasma Treatment Principles |
|
|
317 | (1) |
|
13.4.2 Advantages and Drawbacks of Plasma Treatment |
|
|
318 | (1) |
|
13.4.3 Applications of Plasma Treatment |
|
|
318 | (1) |
|
13.5 Chemical Vapor Deposition |
|
|
319 | (3) |
|
13.5.1 Chemical Vapor Deposition of Inorganic Films |
|
|
319 | (1) |
|
13.5.2 Chemical Vapor Deposition of Polymer Films |
|
|
319 | (3) |
|
13.6 Physical Techniques for Surface Modification |
|
|
322 | (1) |
|
|
322 | (1) |
|
|
323 | (1) |
|
|
323 | (1) |
|
13.10 Solution Processing of Coatings |
|
|
324 | (6) |
|
|
324 | (1) |
|
13.10.2 Langmuir--Blodgett Films |
|
|
325 | (3) |
|
13.10.3 Self-Assembled Monolayers |
|
|
328 | (1) |
|
13.10.4 Layer-by-Layer Deposition |
|
|
329 | (1) |
|
13.11 Biological Functionalization of Biomaterials |
|
|
330 | (7) |
|
13.11.1 Immobilization Methods |
|
|
331 | (1) |
|
13.11.2 Physical Immobilization |
|
|
331 | (1) |
|
13.11.3 Chemical Immobilization |
|
|
332 | (2) |
|
13.11.4 Heparin Modification of Biomaterials |
|
|
334 | (3) |
|
|
337 | (2) |
|
Part IV Degradation of Biomaterials in the Physiological Environment |
|
|
339 | (34) |
|
14 Degradation of Metallic and Ceramic Biomaterials |
|
|
341 | (14) |
|
|
341 | (1) |
|
|
342 | (7) |
|
14.2.1 Principles of Metal Corrosion |
|
|
342 | (3) |
|
|
345 | (1) |
|
|
346 | (1) |
|
14.2.4 Types of Electrochemical Corrosion |
|
|
347 | (2) |
|
14.3 Corrosion of Metal Implants in the Physiological Environment |
|
|
349 | (2) |
|
14.3.1 Minimizing Metal Implant Corrosion in vivo |
|
|
351 | (1) |
|
14.4 Degradation of Ceramics |
|
|
351 | (2) |
|
14.4.1 Degradation by Dissolution and Disintegration |
|
|
351 | (1) |
|
14.4.2 Cell-Mediated Degradation |
|
|
352 | (1) |
|
|
353 | (2) |
|
15 Degradation of Polymeric Biomaterials |
|
|
355 | (18) |
|
|
355 | (1) |
|
15.2 Hydrolytic Degradation |
|
|
356 | (2) |
|
15.2.1 Hydrolytic Degradation Pathways |
|
|
356 | (1) |
|
15.2.2 Role of the Physiological Environment |
|
|
357 | (1) |
|
15.2.3 Effect of Local pH Changes |
|
|
357 | (1) |
|
15.2.4 Effect of Inorganic Ions |
|
|
358 | (1) |
|
15.2.5 Effect of Bacteria |
|
|
358 | (1) |
|
15.3 Enzyme-Catalyzed Hydrolysis |
|
|
358 | (4) |
|
15.3.1 Principles of Enzyme-Catalyzed Hydrolysis |
|
|
359 | (1) |
|
15.3.2 Role of Enzymes in Hydrolytic Degradation in vitro |
|
|
360 | (2) |
|
15.3.3 Role of Enzymes in Hydrolytic Degradation in vivo |
|
|
362 | (1) |
|
15.4 Oxidative Degradation |
|
|
362 | (7) |
|
15.4.1 Principles of Oxidative Degradation |
|
|
363 | (1) |
|
15.4.2 Production of Radicals and Reactive Species in vivo |
|
|
363 | (3) |
|
15.4.3 Role of Radicals and Reactive Species in Degradation |
|
|
366 | (1) |
|
15.4.4 Oxidative Degradation of Polymeric Biomaterials |
|
|
367 | (2) |
|
15.5 Other Types of Degradation |
|
|
369 | (2) |
|
|
369 | (1) |
|
15.5.2 Metal Ion-Induced Oxidative Degradation |
|
|
370 | (1) |
|
15.5.3 Oxidative Degradation Induced by the External Environment |
|
|
370 | (1) |
|
|
371 | (2) |
|
Part V Biocompatibility Phenomena |
|
|
373 | (142) |
|
16 Biocompatibility Fundamentals |
|
|
375 | (26) |
|
|
375 | (1) |
|
16.2 Biocompatibility Phenomena with Implanted Devices |
|
|
375 | (3) |
|
16.2.1 Consequences of Failed Biocompatibility |
|
|
376 | (1) |
|
16.2.2 Basic Pattern of Biocompatibility Processes |
|
|
377 | (1) |
|
16.3 Protein and Cell Interactions with Biomaterial Surfaces |
|
|
378 | (2) |
|
16.3.1 Protein Adsorption onto Biomaterials |
|
|
378 | (1) |
|
16.3.2 Cell-Biomaterial Interactions |
|
|
378 | (2) |
|
16.4 Cells and Organelles |
|
|
380 | (9) |
|
|
380 | (2) |
|
|
382 | (2) |
|
16.4.3 Ribosomes, Endoplasmic Reticulum, and the Golgi Apparatus |
|
|
384 | (2) |
|
|
386 | (1) |
|
|
386 | (2) |
|
16.4.6 Cell Contacts and Membrane Receptors |
|
|
388 | (1) |
|
16.5 Extracellular Matrix and Tissues |
|
|
389 | (4) |
|
16.5.1 Components of the Extracellular Matrix |
|
|
389 | (1) |
|
16.5.2 Attachment Factors |
|
|
389 | (1) |
|
16.5.3 Cell Adhesion Molecules |
|
|
390 | (1) |
|
16.5.4 Molecular and Physical Factors in Cell Attachment |
|
|
391 | (1) |
|
16.5.5 Tissue Types and Origins |
|
|
391 | (2) |
|
16.6 Plasma and Blood Cells |
|
|
393 | (3) |
|
|
393 | (2) |
|
|
395 | (1) |
|
16.7 Platelet Adhesion to Biomaterial Surfaces |
|
|
396 | (1) |
|
16.8 Platelets and the Coagulation Process |
|
|
396 | (2) |
|
16.9 Cell Types and Their Roles in Biocompatibility Phenomena |
|
|
398 | (1) |
|
|
399 | (2) |
|
17 Mechanical Factors in Biocompatibility Phenomena |
|
|
401 | (13) |
|
|
401 | (1) |
|
17.2 Stages and Mechanisms of Mechanotransduction |
|
|
401 | (6) |
|
17.2.1 Force Transduction Pathways |
|
|
401 | (2) |
|
17.2.2 Signal Transduction Pathways and Other Mechanisms |
|
|
403 | (1) |
|
17.2.3 Mechanisms of Cellular Response |
|
|
404 | (3) |
|
17.3 Mechanical Stress-Induced Biocompatibility Phenomena |
|
|
407 | (7) |
|
17.3.1 Implantable Devices in Bone Healing |
|
|
407 | (1) |
|
17.3.2 Implantable Devices in the Cardiovascular System |
|
|
408 | (2) |
|
17.3.3 Soft Tissue Healing |
|
|
410 | (1) |
|
17.3.4 Stem Cells in Tissue Engineering |
|
|
411 | (3) |
|
17 A Outcomes of Transduction of Extracellular Stresses and Responses |
|
|
414 | (3) |
|
|
414 | (3) |
|
18 Inflammatory Reactions to Biomaterials |
|
|
417 | (20) |
|
|
417 | (1) |
|
18.2 Implant Interaction with Plasma Proteins |
|
|
418 | (1) |
|
18.3 Formation of Provisional Matrix |
|
|
418 | (1) |
|
18.4 Acute Inflammation and Neutrophils |
|
|
419 | (4) |
|
18.4.1 Neutrophil Activation and Extravasation |
|
|
419 | (2) |
|
18.4.2 Formation of Reactive Oxygen Species |
|
|
421 | (1) |
|
18.4.3 Phagocytosis by Neutrophils |
|
|
421 | (1) |
|
18.4.4 Neutrophil Extracellular Traps (NETs) |
|
|
421 | (2) |
|
18.4.5 Neutrophil Apoptosis |
|
|
423 | (1) |
|
18.5 Chronic Inflammation and Macrophages |
|
|
423 | (3) |
|
18.5.1 Macrophage Differentiation and Recruitment to Implant Surfaces |
|
|
423 | (1) |
|
18.5.2 Phagocytosis by M1 Macrophages |
|
|
424 | (1) |
|
18.5.3 Generation of Oxidative Radicals by M1 Macrophages |
|
|
425 | (1) |
|
18.5.4 Anti-inflammatory Activities of M2 Macrophages |
|
|
425 | (1) |
|
|
426 | (1) |
|
18.7 Foreign Body Response |
|
|
427 | (2) |
|
18.8 Fibrosis and Fibrous Encapsulation |
|
|
429 | (1) |
|
18.9 Resolution of Inflammation |
|
|
430 | (1) |
|
18.10 Inflammation and Biocompatibility |
|
|
431 | (2) |
|
|
433 | (4) |
|
19 Immune Responses to Biomaterials |
|
|
437 | (12) |
|
|
437 | (1) |
|
19.2 Adaptive Immune System |
|
|
437 | (6) |
|
19.2.1 Lymphocyte Origins of Two Types of Adaptive Immune Defense |
|
|
438 | (1) |
|
19.2.2 Antibody Characteristics and Classes |
|
|
438 | (1) |
|
19.2.3 Major Histocompatibility Complex and Self-Tolerance |
|
|
439 | (1) |
|
19.2.4 B Cell Activation and Release of Antibodies |
|
|
440 | (1) |
|
19.2.5 T Cell Development and Cell-Mediated Immunity |
|
|
440 | (3) |
|
19.3 The Complement System |
|
|
443 | (1) |
|
19.4 Adaptive Immune Responses to Biomaterials |
|
|
443 | (3) |
|
19.4.1 Hypersensitivity Responses |
|
|
444 | (1) |
|
19.4.2 Immune Responses to Protein-Based Biomaterials and Complexes |
|
|
445 | (1) |
|
19.5 Designing Biomaterials to Modulate Immune Responses |
|
|
446 | (1) |
|
|
447 | (2) |
|
20 Implant-Associated Infections |
|
|
449 | (14) |
|
|
449 | (1) |
|
20.2 Bacteria Associated with Implant Infections |
|
|
450 | (1) |
|
20.3 Biofilms and their Characteristics |
|
|
450 | (1) |
|
20.4 Sequence of Biofilm Formation on Implant Surfaces |
|
|
451 | (2) |
|
20.4.1 Passive Reversible Adhesion of Bacteria to Implant Surface |
|
|
452 | (1) |
|
20.4.2 Specific Irreversible Attachment of Bacteria to Implant Surface |
|
|
452 | (1) |
|
20.4.3 Microcolony Expansion and Formation of Biofilm Matrix |
|
|
452 | (1) |
|
20.4.4 Biofilm Maturation and Tower Formation |
|
|
453 | (1) |
|
20.4.5 Dispersal and Return to Planktonic State |
|
|
453 | (1) |
|
20.5 Effect of Biomaterial Characteristics on Bacterial Adhesion |
|
|
453 | (1) |
|
20.6 Biofilm Shielding of Infection from Host Defenses and Antibiotics |
|
|
454 | (1) |
|
20.7 Effects of Biofilm on Host Tissues and Biomaterial Interactions |
|
|
454 | (2) |
|
20.8 Strategies for Controlling Implant Infections |
|
|
456 | (4) |
|
20.8.1 Orthopedic Implants Designed for Rapid Tissue Integration |
|
|
456 | (1) |
|
20.8.2 Surface Nanotopography |
|
|
457 | (1) |
|
20.8.3 Silver Nanoparticles |
|
|
458 | (1) |
|
20.8.4 Anti-biofilm Polysaccharides |
|
|
458 | (1) |
|
20.8.5 Bacteriophage Therapy |
|
|
458 | (1) |
|
20.8.6 Mechanical Disruption |
|
|
459 | (1) |
|
|
460 | (3) |
|
21 Response to Surface Topography and Particulate Materials |
|
|
463 | (36) |
|
|
463 | (1) |
|
21.2 Effect of Biomaterial Surface Topography on Cell Response |
|
|
464 | (7) |
|
21.2.1 Microscale Surface Topography in Osseointegration |
|
|
466 | (3) |
|
21.2.2 Microscale and Nanoscale Patterned Surfaces in Macrophage Differentiation |
|
|
469 | (1) |
|
21.2.3 Microscale Patterned Surfaces in Neural Regeneration |
|
|
470 | (1) |
|
21.3 Biomaterial Surface Topography for Antimicrobial Activity |
|
|
471 | (11) |
|
21.3.1 Microscale Topography with Antimicrobial Activity |
|
|
471 | (6) |
|
21.3.2 Nanoscale Topography with Antimicrobial Activity |
|
|
477 | (5) |
|
21.4 Microparticle-Induced Host Responses |
|
|
482 | (7) |
|
21.4.1 Mechanisms of Microparticle Endocytosis |
|
|
482 | (1) |
|
21.4.2 Response to Microparticles |
|
|
483 | (4) |
|
21.4.3 Microparticle Distribution in the Organs |
|
|
487 | (1) |
|
21.4.4 The Inflammasome and Microparticle-Induced Inflammation |
|
|
488 | (1) |
|
21.4.5 Wear Debris-Induced Osteolysis |
|
|
488 | (1) |
|
21.5 Nanoparticle-Induced Host Responses |
|
|
489 | (7) |
|
21.5.1 Mechanisms of Nanoparticle Endocytosis |
|
|
489 | (1) |
|
21.5.2 Response to Nanoparticles |
|
|
489 | (3) |
|
21.5.3 Cytotoxicity Effects of Nanoparticles |
|
|
492 | (4) |
|
|
496 | (3) |
|
22 Tests of Biocompatibility of Prospective Implant Materials |
|
|
499 | (16) |
|
|
499 | (1) |
|
22.2 Biocompatibility Standards and Regulations |
|
|
499 | (1) |
|
|
499 | (1) |
|
22.2.2 FDA Guidelines and Requirements |
|
|
500 | (1) |
|
22.3 In vitro Biocompatibility Test Procedures |
|
|
500 | (7) |
|
22.3.1 Cytotoxicity Tests |
|
|
500 | (2) |
|
22.3.2 Genotoxicity Tests |
|
|
502 | (2) |
|
22.3.3 Hemocompatibility Tests |
|
|
504 | (3) |
|
22.4 In vivo Biocompatibility Test Procedures |
|
|
507 | (4) |
|
22.4.1 Implantation Tests |
|
|
507 | (2) |
|
22.4.2 Thrombogenicity Tests |
|
|
509 | (1) |
|
22.4.3 Irritation and Sensitization Tests |
|
|
510 | (1) |
|
22.4 A Systemic Toxicity Tests |
|
|
511 | (1) |
|
22.5 Clinical Trials of Biomaterials |
|
|
511 | (1) |
|
22.6 FDA Review and Approval |
|
|
512 | (1) |
|
22.7 Case Study: The Proplast Temporomandibular Joint |
|
|
512 | (1) |
|
|
513 | (2) |
|
Part VI Applications of Biomaterials |
|
|
515 | (166) |
|
23 Biomaterials for Hard Tissue Repair |
|
|
517 | (30) |
|
|
517 | (1) |
|
23.2 Healing of Bone Fracture |
|
|
518 | (3) |
|
23.2.1 Mechanism of Fracture Healing |
|
|
518 | (2) |
|
23.2.2 Internal Fracture Fixation Devices |
|
|
520 | (1) |
|
23.3 Healing of Bone Defects |
|
|
521 | (14) |
|
|
521 | (1) |
|
|
521 | (2) |
|
23.3.3 Bone Graft Substitutes |
|
|
523 | (4) |
|
23.3.4 Healing of Nonstructural Bone Defects |
|
|
527 | (5) |
|
23.3.5 Healing of Structural Bone Defects |
|
|
532 | (3) |
|
23.4 Total Joint Replacement |
|
|
535 | (1) |
|
23.4.1 Total Hip Arthroplasty |
|
|
535 | (1) |
|
23.4.2 Total Knee Arthroplasty |
|
|
536 | (1) |
|
|
536 | (3) |
|
23.5.1 Biomaterials for Spinal Fusion |
|
|
538 | (1) |
|
23.6 Dental Implants and Restorations |
|
|
539 | (4) |
|
|
539 | (1) |
|
23.6.2 Direct Dental Restorations |
|
|
539 | (1) |
|
23.6.3 Indirect Dental Restorations |
|
|
540 | (3) |
|
|
543 | (4) |
|
24 Biomaterials for Soft Tissue Repair |
|
|
547 | (34) |
|
|
547 | (1) |
|
24.2 Surgical Sutures and Adhesives |
|
|
548 | (2) |
|
|
548 | (1) |
|
24.2.2 Soft Tissue Adhesives |
|
|
549 | (1) |
|
24.3 The Cardiovascular System |
|
|
550 | (1) |
|
|
550 | (1) |
|
24.3.2 The Circulatory System |
|
|
551 | (1) |
|
|
551 | (4) |
|
24.4.1 Desirable Properties and Characteristics of Synthetic Vascular Grafts |
|
|
552 | (1) |
|
24.4.2 Synthetic Vascular Graft Materials |
|
|
552 | (1) |
|
24.4.3 Patency of Vascular Grafts |
|
|
552 | (3) |
|
|
555 | (1) |
|
24.6 Intravascular Stents |
|
|
556 | (2) |
|
|
556 | (1) |
|
24.6.2 Drug-Eluting Stents |
|
|
557 | (1) |
|
|
557 | (1) |
|
24.7 Prosthetic Heart Valves |
|
|
558 | (2) |
|
|
558 | (1) |
|
24.7.2 Bioprosthetic Valves |
|
|
559 | (1) |
|
24.8 Ophthalmologic Applications |
|
|
560 | (6) |
|
|
561 | (2) |
|
24.8.2 Intraocular Lenses |
|
|
563 | (3) |
|
|
566 | (10) |
|
24.9.1 Skin Wound Healing Fundamentals |
|
|
567 | (2) |
|
24.9.2 Complicating Factors in Skin Wound Healing |
|
|
569 | (1) |
|
24.9.3 Biomaterials-Based Therapies |
|
|
569 | (5) |
|
24.9.4 Nanoparticle-Based Therapies |
|
|
574 | (2) |
|
|
576 | (5) |
|
25 Biomaterials for Tissue Engineering and Regenerative Medicine |
|
|
581 | (52) |
|
|
581 | (1) |
|
25.2 Principles of Tissue Engineering and Regenerative Medicine |
|
|
582 | (7) |
|
25.2.1 Cells for Tissue Engineering |
|
|
584 | (3) |
|
25.2.2 Biomolecules and Nutrients for in vitro Cell Culture |
|
|
587 | (1) |
|
25.2.3 Growth Factors for Tissue Engineering |
|
|
587 | (1) |
|
|
588 | (1) |
|
|
589 | (1) |
|
25.3 Biomaterials and Scaffolds for Tissue Engineering |
|
|
589 | (6) |
|
25.3.1 Properties of Scaffolds for Tissue Engineering |
|
|
589 | (2) |
|
25.3.2 Biomaterials for Tissue Engineering Scaffolds |
|
|
591 | (1) |
|
|
591 | (3) |
|
|
594 | (1) |
|
25.3.5 Extracellular Matrix (ECM) Scaffolds |
|
|
594 | (1) |
|
25.4 Creation of Scaffolds for Tissue Engineering |
|
|
595 | (14) |
|
25.4.1 Creation of Scaffolds in the Form of Porous Solids |
|
|
596 | (5) |
|
|
601 | (2) |
|
25.4.3 Additive Manufacturing (3D Printing) Techniques |
|
|
603 | (5) |
|
25.4.4 Formation of Hydrogel Scaffolds |
|
|
608 | (1) |
|
25.4.5 Preparation of Extracellular Matrix (ECM) Scaffolds |
|
|
608 | (1) |
|
25.5 Three-dimensional Bioprinting |
|
|
609 | (5) |
|
25.5.1 Inkjet-Based Bioprinting |
|
|
609 | (2) |
|
25.5.2 Microextrusion-Based Bioprinting |
|
|
611 | (3) |
|
25.6 Tissue Engineering Techniques for the Regeneration of Functional Tissues and Organs |
|
|
614 | (15) |
|
25.6.1 Bone Tissue Engineering |
|
|
614 | (1) |
|
25.6.2 Articular Cartilage Tissue Engineering |
|
|
615 | (3) |
|
25.6.3 Tissue Engineering of Articular Joints |
|
|
618 | (3) |
|
25.6.4 Tissue Engineering of Tendons and Ligaments |
|
|
621 | (3) |
|
25.6.5 Skin Tissue Engineering |
|
|
624 | (2) |
|
25.6.6 Bladder Tissue Engineering |
|
|
626 | (3) |
|
|
629 | (4) |
|
26 Biomaterials for Drug Delivery |
|
|
633 | (48) |
|
|
633 | (1) |
|
26.2 Controlled Drug Release |
|
|
634 | (4) |
|
26.2.1 Drug Delivery Systems |
|
|
636 | (1) |
|
26.2.2 Mechanisms of Drug Release |
|
|
636 | (2) |
|
26.3 Designing Biomaterials for Drug Delivery Systems |
|
|
638 | (1) |
|
26.4 Microparticle-based Delivery Systems |
|
|
638 | (2) |
|
26.4.1 Preparation of Polymer Microsphere Delivery Systems |
|
|
639 | (1) |
|
26.4.2 Applications of Microparticle Delivery Systems |
|
|
640 | (1) |
|
26.5 Hydrogel-based Delivery Systems |
|
|
640 | (8) |
|
26.5.1 Environmentally Responsive Drug Delivery Systems |
|
|
641 | (3) |
|
26.5.2 Drug Delivery Systems Responsive to External Physical Stimuli |
|
|
644 | (4) |
|
26.6 Nanoparticle-based Delivery Systems |
|
|
648 | (20) |
|
26.6.1 Distribution and Fate of Nanoparticle-based Drug Delivery Systems |
|
|
649 | (1) |
|
26.6.2 Targeting of Nanoparticles to Cells |
|
|
650 | (3) |
|
26.6.3 Polymer-based Nanoparticle Systems |
|
|
653 | (2) |
|
26.6.4 Lipid-based Nanoparticle Systems |
|
|
655 | (8) |
|
26.6.5 Polymer Conjugates |
|
|
663 | (3) |
|
|
666 | (1) |
|
26.6.7 Inorganic Nanoparticles |
|
|
667 | (1) |
|
26.7 Delivery of Ribonucleic Acid (RNA) |
|
|
668 | (7) |
|
26.7.1 Chemical Modification of siRNA |
|
|
670 | (1) |
|
26.7.2 Biomaterials for siRNA Delivery |
|
|
671 | (4) |
|
26.8 Biological Drug Delivery Systems |
|
|
675 | (1) |
|
26.8.1 Exosomes for Therapeutic Biomolecule Delivery |
|
|
675 | (1) |
|
|
676 | (5) |
Index |
|
681 | |